Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma
- 30 June 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Human Genetics
- Vol. 62 (1), 49-56
- https://doi.org/10.1038/jhg.2016.84
Abstract
Journal of Human Genetics, official journal of the Japan Society of Human Genetics, publishes original articles and reviews on all aspects of human genetics, including medical genetics and genomicsKeywords
This publication has 89 references indexed in Scilit:
- The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerBritish Journal of Cancer, 2011
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2The Journal of Experimental Medicine, 2011
- miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerBritish Journal of Cancer, 2010
- MicroRNA-143 as a Tumor Suppressor for Bladder CancerJournal of Urology, 2009
- Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocationThe Journal of Experimental Medicine, 2008
- A reciprocal repression between ZEB1 and members of the miR‐200 family promotes EMT and invasion in cancer cellsEMBO Reports, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006